Hereditary Tyrosinemia Pathogenesis, Screening and Management /
Hereditary tyrosinemia type 1 (HT1), the most severe inborn error of the tyrosine degradation pathway, is due to a deficiency in fumarylacetoacetate hydrolase (FAH). The worldwide frequency of HT1 is one per 100,000 births, but some regions have a significantly higher incidence (1:1,800). The FAH de...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Edition: | 1st ed. 2017. |
| Series: | Advances in Experimental Medicine and Biology,
959 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-319-55780-9 |